To report a case of acute angioedema following hyaluronic acid filler and onabotulinumtoxinA injection in an individual with allergies, recent viral vaccination, and polymyalgia rheumatica. This is a retrospective case report. A 63-year-old female with a history of allergies, asthma, and polymyalgia rheumatica on lisinopril presented with angioedema 4 hours following facial filler injection and botulinum toxin injection. The patient was successfully treated with epinephrine, diphenhydramine, and methylprednisolone. Although cosmetic injections are commonly performed, clinicians must be vigilant about rare, yet serious side-effects such as angioedema. This case underscores the importance of thoroughly evaluating medical histories before cosmetic injections and addressing patient concerns after the procedure.
SundaramHSignoriniMLiewS, et al. Global aesthetics consensus: botulinum toxin type A—evidence-based review, emerging concepts, and consensus recommendations for aesthetic use, including updates on complications. Plast Reconstr Surg. 2016;137(3):518e-529e.
FaivreJPigwehAIIehlJMaffertPGoekjianPBourdonF.Crosslinking hyaluronic acid soft-tissue fillers: current status and perspectives from an industrial point of view. Expert Rev Med Devices. 2021;18(12):1175-1187.
GuoJFangWWangF.Injectable fillers: current status, physicochemical properties, function mechanism, and perspectives. RSC Adv. 2023;13(34):23841-23858.
8.
ZargaranDZollerFZargaranA, et al. Complications of cosmetic botulinum toxin A injections to the upper face: a systematic review and meta-analysis. Aesthet Surg J. 2022;42(5):NP327-NP336.
9.
DayanSBruceSKilmerS, et al. Safety and effectiveness of the hyaluronic acid filler, HYC-24L, for lip and perioral augmentation. Dermatol Surg. 2015;41(suppl 1):S293-S301.
10.
Mahmood FarisBJ. The use of facial fillers in clinical practice: the level of patient satisfaction and an overview of common clinical complications. Actas Dermosifiliogr. 2024;115(5):458-465.
11.
BernsteinJACremonesiPHoffmannTKHollingsworthJ.Angioedema in the emergency department: a practical guide to differential diagnosis and management. Int J Emerg Med. 2017;10(1):15.
12.
VleemingWvan AmsterdamJGStrickerBHde WildtDJ.ACE inhibitor-induced angioedema. Incidence, prevention and management. Drug Saf. 1998;18(3):171-188.
13.
VirdiG.Dermal fillers and COVID-19: angioedema with urticaria in a patient post COVID-19 infection. Cureus. 2022;14(4):e24461.
14.
Padilla-PantojaFDFakih-GomezNMunoz-GonzalezC, et al. Temporary delayed hypersensitivity reaction to botulinum toxin-A after COVID-19 vaccination: a case series. Aesthetic Plast Surg. 2024;47:1-9.
15.
TurkmaniMGDe BoulleKPhilipp-DormstonWG.Delayed hypersensitivity reaction to hyaluronic acid dermal filler following influenza-like illness. Clin Cosmet Investig Dermatol. 2019;12:277-283.
16.
RocheNEFulbrightJWWagnerADHunderGGGoronzyJJWeyandCM.Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis. Arthritis Rheum. 1993;36(9):1286-1294.
17.
DecatesTSVelthuisPJSchelkeLW, et al. Increased risk of late-onset, immune-mediated, adverse reactions related to dermal fillers in patients bearing HLA-B*08 and DRB1*03 haplotypes. Dermatol Ther. 2021;34(1):e14644.
18.
CosattiMFernández RomeroDSJuriMCMalbránA.[Facial angioedema after filler injections. Description of five cases]. Medicina (B Aires). 2010;70(6):513-517.
BulamHSezginBTuncerSFindikciogluKCenetogluS.A severe acute hypersensitivity reaction after a hyaluronic acid with lidocaine filler injection to the lip. Arch Plast Surg. 2015;42(2):245-247.
21.
MoonIJChangSEKimSD.First case of anaphylaxis after botulinum toxin type A injection. Clin Exp Dermatol. 2017;42(7):760-762.
